YALL God Bless America ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 6.38% |
| TSLA | 5.98% |
| AVGO | 5.69% |
| EA | 5.21% |
| COST | 5.10% |
| HCA | 4.93% |
| SCHW | 4.60% |
| PLTR | 4.32% |
| BA | 4.24% |
| CHTR | 4.23% |
ETF Analysis
Fund Overview
God Bless America ETF (YALL) currently reports 41 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is NVDA (6.38%), TSLA (5.98%), AVGO (5.69%), with NVDA as the largest single weight at 6.38%. Together, the top three holdings account for 18.05%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.
Profitability & Capital Efficiency
On the question of capital productivity, ROIC is 31.44%, WACC is 9.63%, and the economic spread is 21.81%. On balance, the economic spread is positive and meaningful, suggesting the underlying holdings are building rather than eroding intrinsic value. Supporting metrics show ROE at 45.39% and ROA at 9.01%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
Assessed on a multiple basis, trailing P/E of 25.67, forward P/E of 16.06, PEG of 3.11. Forward P/E comes in somewhat below trailing — a gap that is supportive of the valuation case without implying a sharp near-term earnings inflection. At this PEG level, the valuation case rests more on quality, scarcity, or market leadership than on earnings growth alone. The portfolio carries an aggregate current ratio of 2.00, consistent with adequate near-term liquidity management. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.
Margins & Cash Generation
The margin stack reads as follows: gross margin sits at 52.73%, operating margin at 22.01%, and free cash flow margin at 22.53%. The gross margin reading points to holdings with solid but not outsized pricing power relative to direct costs. The portfolio's operating margins are solid, pointing to holdings where overhead management is a relative strength. FCF margins are constructive here, reflecting holdings that generate cash reliably after reinvestment requirements. The margin profile across gross, operating, and free cash flow levels is consistently strong — a rare combination that typically indicates durable business quality.
Growth & Forward Outlook
The forward view combines two signals: the estimated 12-month price change of 22.04%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 16.69% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 59.8% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyPutting all the pieces together, the fundamental picture is one of the more convincing setups in these metrics — strong capital returns, reasonable pricing, and a healthy forward outlook.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.